Search Results for "fexofenadine"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for fexofenadine. Results 21 to 27 of 27 total matches.
See also: Allegra

Drug Interactions with Grapefruit Juice

   
The Medical Letter on Drugs and Therapeutics • Jan 05, 2004  (Issue 1173)
with multiple doses; amlodipine is minimally affected Fexofenadine (Allegra) Possible decreased effect Large ...
The ability of grapefruit juice to increase serum concentrations of drugs was first discovered during a study of the effect of ethanol on felodipine (Plendil) pharmacokinetics. Double-strength grapefruit juice used to disguise the taste of ethanol resulted in higher than expected serum concentrations of felodipine (DG Bailey et al, Clin Invest Med 1989; 12:357).
Med Lett Drugs Ther. 2004 Jan 5;46(1173):2-4 |  Show IntroductionHide Introduction

OTC Drugs for Seasonal Allergies

   
The Medical Letter on Drugs and Therapeutics • Apr 22, 2019  (Issue 1570)
less likely than first-generation drugs to cause CNS impairment and sedation.8,9 Fexofenadine does ...
Patients with seasonal allergies often experience nasal itching and congestion, sneezing, rhinorrhea, and itchy, watery eyes. Oral, intranasal, and ophthalmic preparations are widely available over the counter (OTC) for relief of symptoms. Prescription products for management of allergic rhinitis and allergic conjunctivitis are reviewed separately.
Med Lett Drugs Ther. 2019 Apr 22;61(1570):57-60 |  Show IntroductionHide Introduction

Treatment of Allergic Rhinitis and Allergic Conjunctivitis

   
The Medical Letter on Drugs and Therapeutics • Mar 31, 2025  (Issue 1725)
Fexofenadine (Allegra, and others) is nonsedating and does not cause CNS impairment, even in higher-than ...
Initial treatment of allergic rhinitis (AR) depends on the severity of symptoms and whether they are intermittent or persistent (see Table 1).
Med Lett Drugs Ther. 2025 Mar 31;67(1725):49-56   doi:10.58347/tml.2025.1725a |  Show IntroductionHide Introduction

Drugs that may cause Cognitive Disorders in the Elderly

   
The Medical Letter on Drugs and Therapeutics • Nov 27, 2000  (Issue 1093)
-receptor blockers Impaired attention, decreased concentration Fexofenadine, loratadine least likely ...
Older patients are especially susceptible to drug-induced cognitive impairment. They are more likely to be taking multiple drugs, to have higher blood levels of those drugs because of renal or hepatic dysfunction, and to have pre-existing cognitive problems that make it difficult to detect the role of drugs causing new symptoms or making old ones worse.
Med Lett Drugs Ther. 2000 Nov 27;42(1093):111-2 |  Show IntroductionHide Introduction

Two New Drugs for Homozygous Familial Hypercholesterolemia

   
The Medical Letter on Drugs and Therapeutics • Apr 01, 2013  (Issue 1413)
-glycoprotein (P-gp) inhibitor. Serum concentrations of P-gp substrates such as fexofenadine, saxagliptin ...
The FDA has approved mipomersen (Kynamro – Genzyme) and lomitapide (Juxtapid – Aegerion), each in addition to a low-fat diet and other lipid-lowering medications, to reduce cholesterol levels in patients with homozygous familial hypercholesterolemia (HoFH).
Med Lett Drugs Ther. 2013 Apr 1;55(1413):25-7 |  Show IntroductionHide Introduction

Drugs in the Elderly

   
The Medical Letter on Drugs and Therapeutics • Jan 16, 2006  (Issue 1226)
, and others) diphenhydramine and promethazine, are as fexofenadine (Allegra) or loratadine Hydroxyzine ...
The physiologic changes that occur with aging can affect the pharmacokinetics and pharmacodynamics of many prescription and over-the-counter drugs, increasing the likelihood of adverse effects.
Med Lett Drugs Ther. 2006 Jan 16;48(1226):6-7 |  Show IntroductionHide Introduction

Drugs for Cough

   
The Medical Letter on Drugs and Therapeutics • Dec 17, 2018  (Issue 1562)
of fexofenadine, diphenhydramine, and alcohol on driving performance. A randomized, placebocontrolled trial ...
Acute cough (<3 weeks in duration) generally does not require pharmacologic treatment, especially in children. Suppression of productive cough may be harmful. Management of patients with cough should include elimination of any precipitating factor (e.g., cigarette smoking) and treatment of any underlying cause such as upper airway cough syndrome, gastroesophageal reflux disease, asthma, or other pulmonary disease.
Med Lett Drugs Ther. 2018 Dec 17;60(1562):206-8 |  Show IntroductionHide Introduction